Research theme for competitive and other funds (2)：
2022 - 2025 関節リウマチにおけるI型インターフェロン-HGF axisの機能解析
2020 - 2023 高齢発症関節リウマチにおけるCD8陽性制御性T細胞の機能解析
Papers (99)：
Takayuki Fujii, Koichi Murata, Hideo Onizawa, Akira Onishi, Masao Tanaka, Kosaku Murakami, Kohei Nishitani, Moritoshi Furu, Ryu Watanabe, Motomu Hashimoto, et al. Management and treatment outcomes of rheumatoid arthritis in the era of biologic and targeted synthetic therapies: evaluation of 10-year data from the KURAMA cohort. Arthritis Research and Therapy. 2024. 26. 1
Takeshi Iwasaki, Ryu Watanabe, Hui Zhang, Motomu Hashimoto, Akio Morinobu, Fumihiko Matsuda. Identification of the VLDLR locus associated with giant cell arteritis and the possible causal role of low-density lipoprotein cholesterol in its pathogenesis. Rheumatology. 2024
Shozo Ohtsuki, Chenyao Wang, Ryu Watanabe, Hui Zhang, Mitsuhiro Akiyama, Melanie C Bois, Joseph J Maleszewski, Kenneth J Warrington, Gerald J Berry, Jörg J Goronzy, et al. Deficiency of the CD155-CD96 immune checkpoint controls IL-9 production in giant cell arteritis. Cell reports. Medicine. 2023. 4. 4. 101012-101012
Eriho Yamaguchi, Keiichiro Kadoba, Ryu Watanabe, Motomu Hashimoto, Akio Morinobu, Hajime Yoshifuji. Response to: 'Biases in Large Vessel Vasculitis' by Mukhtyar. Modern rheumatology. 2023
Ryu Watanabe, Keiichiro Kadoba, Atsuko Tamamoto, Koichi Murata, Kosaku Murakami, Hideo Onizawa, Takayuki Fujii, Akira Onishi, Masao Tanaka, Hiromu Ito, et al. CD8+ Regulatory T Cell Deficiency in Elderly-Onset Rheumatoid Arthritis. Journal of clinical medicine. 2023. 12. 6
